Clinical trials are essential research studies that determine the safety and efficacy of new medicines. At Novo Nordisk, our potential treatments begin their journey in laboratory settings, with promising candidates advancing to carefully designed human studies.

Our clinical trials assess whether new treatments effectively improve patient outcomes, slow disease progression, or provide symptom relief. These studies also rigorously evaluate safety profiles and identify potential side effects.

Clinical trials form the foundation of evidence-based medicine. Every medication available today – whether prescribed by your doctor or purchased at your pharmacy – has undergone this thorough testing process. These studies generate crucial data about efficacy and safety that guide healthcare providers in treatment decisions and help regulatory authorities determine which medications receive approval.

While we aim to discover improved treatments, not every clinical trial yields a superior medication. Sometimes, a new treatment may not outperform existing options or may present different side effect profiles. However, these findings remain valuable, contributing to our scientific understanding and ultimately benefitting future patients.

At Novo Nordisk Australia, we are committed to pioneering scientific breakthroughs that drive change in defeating serious chronic diseases. Our extensive clinical trials program in Australia demonstrates our dedication to innovation and improving patient outcomes.

Our in-house clinical development team, which consists of 45 full-time staff, manages commercialisation and patient access for all clinical trials in collaboration with our local investigators.